We are live on ! Find out more
EUDAW icon

EUDA Health Holdings Warrant

11 hedge funds and large institutions have $146K invested in EUDA Health Holdings Warrant in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

51% more capital invested

Capital invested by funds: $96.7K → $146K (+$49.6K)

0% more funds holding

Funds holding: 1111 (0)

0.21% less ownership

Funds ownership: 6.28%6.07% (-0.21%)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
11
Holders Change
Holders Change %
0%
% of All Funds
0.16%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
1
Reduced
2
Closed
Calls
Puts
Net Calls
Net Calls Change

EUDAW Hedge Fund Activity: Q4 2023 in Review

11 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in EUDA Health Holdings Warrant (EUDAW) for Q4 2023, worth a combined $146K — up 51% from $96.7K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new EUDAW positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 2 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $1.13K. The largest seller was Yakira Capital Management, cutting an estimated $1.43K.

  • 11 institutional investors held EUDA Health Holdings Warrant (EUDAW) as of Q4 2023, unchanged from Q3 2023.
  • Funds reported $146K of EUDA Health Holdings Warrant stock for Q4 2023, up 51% quarter-over-quarter.
  • 1 fund opened new EUDA Health Holdings Warrant positions in Q4 2023 and 0 closed out, a net change of +1 holder.
  • The largest EUDA Health Holdings Warrant buyer in Q4 2023 was Citadel Advisors, an estimated $1.13K added.
  • The largest EUDA Health Holdings Warrant seller in Q4 2023 was Yakira Capital Management, an estimated $1.43K sold.

Based on aggregated 13F filings for Q4 2023.